Hey Dave, the roadshow presentation is the first time we've seen neoPOLEM on the milestone (now value inflection points) chart. However, a review of the presentations going all the way back to May last year shows that it has been staring us in the face for some time
The really valuable tidbit was the info provided by Outlander from Nick Ede: that IMU was approached to run this one. We're often told there are some products out there trying to find a market. But here we have the market coming to IMU. That really reaffirms Imugene's view that the B cell platform has been "validated".
If a bunch of "world class" oncologists approached Imugene to get a trial running using the B Cell tech, it's not too hard to imagine that Big Pharma have also approached Imugene looking for a deal. The word is clearly out amongst those who know.
GLTAH.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |